Education
About Us
Working with TipRanks
Follow Us
Beauty Health (SKIN)
NASDAQ:SKIN
SKIN Stock Chart & Stats
$1.52
-$0.07(-3.95%)
At close: 4:00 PM EST
$1.52
-$0.07(-3.95%)
Day’s Range― - ―
52-Week Range$0.78 - $2.69
Previous CloseN/A
Volume138.49K
Average Volume (3M)1.04M
Market Cap
$193.80M
Enterprise Value$353.39M
Total Cash (Recent Filing)$219.40M
Total Debt (Recent Filing)$378.98M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Mar 18, 2026EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding127,503,060
10 Day Avg. Volume926,645
30 Day Avg. Volume1,036,656
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)3.80
Price to Sales (P/S)0.59
P/FCF Ratio21.08
Enterprise Value/Market Cap1.82
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit1.81
Enterprise Value/Ebitda12.13
Forecast
1Y Price Target
$2.05Price Target Upside34.87% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Leadership And ProfitabilityNew leadership establishes a clearer path to profitability and margin expansion, which could increase investor confidence and support a re-rating of the stock.
Margin Mix ImprovementPlanned exit from low-margin delivery systems is expected to improve equipment margins and set a stronger margin baseline heading into 2026.
Product Positioning And DemandStrong positioning in personalized, science-backed skin health and less invasive treatments could capture category tailwinds and drive higher device and consumables demand.
Bears Say
APAC Distribution TransitionShift to a distributor model in China has led to a material sales decrease in APAC, which could delay recovery of international consumables revenue.
Device Churn And UtilizationElevated device churn and attrition among low-volume providers reduce repeat-treatment revenue and raise costs for equipment replacement and customer retention.
Macroeconomic Pressure On Device SalesWeak macroeconomic conditions and tighter access to financing are contributing to continued declines in device placements, pressuring top-line growth.
Beauty Health News
SKIN FAQ
What was Beauty Health’s price range in the past 12 months?
Beauty Health lowest stock price was $0.78 and its highest was $2.69 in the past 12 months.
What is Beauty Health’s market cap?
Beauty Health’s market cap is $193.80M.
When is Beauty Health’s upcoming earnings report date?
Beauty Health’s upcoming earnings report date is Mar 18, 2026 which is in 50 days.
How were Beauty Health’s earnings last quarter?
Beauty Health released its earnings results on Nov 06, 2025. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.074 by -$0.016.
Is Beauty Health overvalued?
According to Wall Street analysts Beauty Health’s price is currently Undervalued.
Does Beauty Health pay dividends?
Beauty Health does not currently pay dividends.
What is Beauty Health’s EPS estimate?
Beauty Health’s EPS estimate is -0.05.
How many shares outstanding does Beauty Health have?
Beauty Health has 127,503,060 shares outstanding.
What happened to Beauty Health’s price movement after its last earnings report?
Beauty Health reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.074. Following the earnings report the stock price went up 8.527%.
Which hedge fund is a major shareholder of Beauty Health?
Currently, no hedge funds are holding shares in SKIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.05 (34.87% Upside)
$2.05 (34.87% Upside)
Hedge Fund Trend
Increased
By 4.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 10.0%
Last 30 Days ▲ 10.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.85%
12-Months-Change
Fundamentals
Return on Equity
-18.73%
Trailing 12-Months
Asset Growth
-28.70%
Trailing 12-Months
Company Description
Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
SKIN Company Deck
SKIN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative elements. On the positive side, there was growth in adjusted EBITDA, an improved consumable mix, successful new product launches, and significant inventory management achievements. However, these were countered by declines in overall revenue, significant drops in the device segment and APAC revenues, and concerns about the churn rate among providers. While operational improvements and strategic initiatives offer promise, the ongoing pressures in device sales and regional performance present notable challenges.View all SKIN earnings summariesSKIN Stock 12 Month Forecast
Average Price Target
$2.05
▲(34.87% Upside)
Technical Analysis
Ownership Overview
14.50% Insiders
13.73% Mutual Funds
0.03% Other Institutional Investors
63.69% Public Companies and
Individual Investors